Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oragenics Inc (NY: OGEN ) 0.9010 +0.0010 (+0.11%) Streaming Delayed Price Updated: 10:40 AM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 157,523 Open 0.9400 Bid (Size) 0.9010 (3) Ask (Size) 0.9148 (10) Prev. Close 0.9000 Today's Range 0.9000 - 0.9400 52wk Range 0.8611 - 7.740 Shares Outstanding 5,580,693 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Completes Manufacture, Filling of Intranasal Device for Use in Upcoming Clinical Trial August 21, 2024 Via Investor Brand Network EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injury August 21, 2024 Oragenics completes the formulation and filling of its nasal spray drug, ONP-002, for concussion treatment, aiming to launch a Phase 2a trial. Via Benzinga Performance YTD -86.71% -86.71% 1 Month -14.19% -14.19% 3 Month -58.67% -58.67% 6 Month -72.61% -72.61% 1 Year -70.07% -70.07% More News Read More BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Reports on Status of Lead Drug Candidate Designed to Treat Concussion August 19, 2024 Via Investor Brand Network Exposures Product Safety “Explosive Growth Stocks: Innovations, Strategy, Earners Unlock Prime Potential CXAI, OGEN, PRSO, INBS, KAVL” August 14, 2024 Via AB Newswire Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety OGEN Stock Earnings: Oragenics Reported Results for Q2 2024 August 12, 2024 Via InvestorPlace OGEN Stock Earnings: Oragenics Reported Results for Q4 2023 June 28, 2024 Via InvestorPlace Why Oragenics (OGEN) Shares Are Falling June 25, 2024 Via Benzinga OGEN Stock Earnings: Oragenics Reported Results for Q1 2024 May 15, 2024 Via InvestorPlace As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032 August 09, 2024 Via FinancialNewsMedia EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway August 08, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session June 05, 2024 Via Benzinga Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results May 22, 2024 Via Benzinga Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 22, 2024 Via Benzinga Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings May 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session May 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 07, 2024 Via Benzinga Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards April 19, 2024 From Oragenics, Inc. Via Business Wire Oragenics, Inc. Files 10K and Provides Company Update April 01, 2024 From Oragenics, Inc. Via Business Wire Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion March 18, 2024 From Oragenics, Inc. Via Business Wire Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion March 05, 2024 From Oragenics, Inc. Via Business Wire Oragenics Announces Closing of Public Offering March 01, 2024 From Oragenics, Inc. Via Business Wire S&P 500 Edges Lower; ADT Posts Upbeat Earnings February 28, 2024 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
